Abstract
Background: Genetic and environmental risk factors are assumed to contribute to the susceptibility to cervical artery dissection (CeAD). To explore the role of genetic imbalance in the etiology of CeAD, copy number variants (CNVs) were identified in high-density microarrays samples from the multicenter CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) study and from control subjects from the CADISP study and the German PopGen biobank. Microarray data from 833 CeAD patients and 2040 control subjects (565 subjects with ischemic stroke due to causes different from CeAD and 1475 disease-free individuals) were analyzed. Rare genic CNVs were equally frequent in CeAD-patients (16.4%; n=137) and in control subjects (17.0%; n=346) but differed with respect to their genetic content. Compared to control subjects, CNVs from CeAD patients were enriched for genes associated with muscle organ development and cell differentiation, which suggests a possible association with arterial development. CNVs affecting cardiovascular system development were more common in CeAD patients than in control subjects (p=0.003; odds ratio (OR) =2.5; 95% confidence interval (95% CI) =1.4-4.5) and more common in patients with a familial history of CeAD than in those with sporadic CeAD (p=0.036; OR=11.2; 95% CI=1.2-107).
Conclusion: The findings suggest that rare genetic imbalance affecting cardiovascular system development may contribute to the risk of CeAD. Validation of these findings in independent study populations is warranted.Keywords: Copy number variation, Cervical artery dissection, Rare genetic variation, Cardiovascular system development.
Graphical Abstract
Current Genomics
Title:Genetic Imbalance in Patients with Cervical Artery Dissection
Volume: 18 Issue: 2
Author(s): Antti J. Metso, for the CADISP group, Stefan T. Engelter, Philippe A. Lyrer, Didier Leys, Turgut Tatlisumak, Elisabetta Del Zotto, Emmanuel Touze, Vincent Thijs, Stefan Schreiber, Christopher Traenka, Alessandro Pezzini, Christoph Lichy, Manja Kloss, Armin J. Grau, Tiina M. Metso, Caspar Grond-Ginsbach, Juan-Jose Martin, Giacomo Giacalone, Andreas Geschwendtner, Martin Dichgans, Stephanie Debette, Valeria Caso, Tobias Brandt, Anna Bersano, Marie-Luise Arnold, Sherine Abboud, Yanxiang Jiang, Philip Ginsbach, Rastislav Pjontek, Michael Krawczak and Bowang Chen
Affiliation:
Keywords: Copy number variation, Cervical artery dissection, Rare genetic variation, Cardiovascular system development.
Abstract: Background: Genetic and environmental risk factors are assumed to contribute to the susceptibility to cervical artery dissection (CeAD). To explore the role of genetic imbalance in the etiology of CeAD, copy number variants (CNVs) were identified in high-density microarrays samples from the multicenter CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) study and from control subjects from the CADISP study and the German PopGen biobank. Microarray data from 833 CeAD patients and 2040 control subjects (565 subjects with ischemic stroke due to causes different from CeAD and 1475 disease-free individuals) were analyzed. Rare genic CNVs were equally frequent in CeAD-patients (16.4%; n=137) and in control subjects (17.0%; n=346) but differed with respect to their genetic content. Compared to control subjects, CNVs from CeAD patients were enriched for genes associated with muscle organ development and cell differentiation, which suggests a possible association with arterial development. CNVs affecting cardiovascular system development were more common in CeAD patients than in control subjects (p=0.003; odds ratio (OR) =2.5; 95% confidence interval (95% CI) =1.4-4.5) and more common in patients with a familial history of CeAD than in those with sporadic CeAD (p=0.036; OR=11.2; 95% CI=1.2-107).
Conclusion: The findings suggest that rare genetic imbalance affecting cardiovascular system development may contribute to the risk of CeAD. Validation of these findings in independent study populations is warranted.Export Options
About this article
Cite this article as:
Metso J. Antti, for the CADISP group , Engelter T. Stefan, Lyrer A. Philippe, Leys Didier, Tatlisumak Turgut, Zotto Del Elisabetta, Touze Emmanuel, Thijs Vincent, Schreiber Stefan, Traenka Christopher, Pezzini Alessandro, Lichy Christoph, Kloss Manja, Grau J. Armin, Metso M. Tiina, Grond-Ginsbach Caspar, Martin Juan-Jose, Giacalone Giacomo, Geschwendtner Andreas, Dichgans Martin, Debette Stephanie, Caso Valeria, Brandt Tobias, Bersano Anna, Arnold Marie-Luise, Abboud Sherine, Jiang Yanxiang, Ginsbach Philip, Pjontek Rastislav, Krawczak Michael and Chen Bowang, Genetic Imbalance in Patients with Cervical Artery Dissection, Current Genomics 2017; 18 (2) . https://dx.doi.org/10.2174/1389202917666160805152627
DOI https://dx.doi.org/10.2174/1389202917666160805152627 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing
Current Pharmaceutical Design Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Targeting Inflammation in Primary Cardiovascular Prevention
Current Pharmaceutical Design Immune and Metabolic Interactions of Human Erythrocytes: A Molecular Perspective
Endocrine, Metabolic & Immune Disorders - Drug Targets Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design ABC Transporters and Sterol Absorption
Current Drug Targets - Cardiovascular & Hematological Disorders Obesity, Hypertension and Hypercholesterolemia as Risk Factors for Atherosclerosis Leading to Ischemic Events
Current Medicinal Chemistry Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges
Current Diabetes Reviews Family History and Preclinical Atherosclerosis
Current Hypertension Reviews High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design Nitric Oxide and Dietary Factors: Part I Nitric Oxide Synthesis and Action
Vascular Disease Prevention (Discontinued) Epidemiology of NHP-Drug Interactions: Identification and Evaluation
Current Drug Metabolism Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets Platelet Function Testing in Atherothrombotic Disease
Current Pharmaceutical Design Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents Editorial [ Hot Topic:Stroke Bugs: Current and Emerging Concepts Relevant to Infection in Cerebrovascular Disease (Guest Editors: Hedley CA Emsley and Angel Chamorro)]
Infectious Disorders - Drug Targets The Relationship Between Cleft Lip, Maxillary Hypoplasia, Hypoxia and Phenytoin
Current Pharmaceutical Design Ezetimibe Therapy for Dyslipidemia: An Update
Current Pharmaceutical Design Fine Tuning Therapeutic Targeting of the Sphingolipid Biosynthetic Pathway to Treat Atherosclerosis
Current Vascular Pharmacology